Human Ciliary Neurotrophic Factor

Human Ciliary Neurotrophic Factor Uses, Dosage, Side Effects, Food Interaction and all others data.

Human Ciliary Neurotrophic Factor (NT-501) is Neurotech's lead product which is in two Phase II/III clinical trials for the treatment of visual loss associated with retinitis pigmentosa and a Phase II trial for the treatment of the dry form of age-related macular degeneration. Neurotech is also evaluating other factors that can be used with its proprietary delivery technology, Encapsulated Cell Technology (ECT), to treat additional retinal diseases.

Human Ciliary Neurotrophic Factor
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Human Ciliary Neurotrophic Factor
Generic	Ciliary neurotrophic factor
Ciliary neurotrophic factor Other Names	Ciliary neurotrophic factor (human), Human ciliary neurotrophic factor, Human CNTF
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in eye disorders/infections, macular degeneration, and retinal disorders (unspecified).

How Human Ciliary Neurotrophic Factor works

NT-501 is an intraocular, cell containing polymer implant designed to provide the continuous, long-term release of the therapeutic protein, Ciliary Neurotrophic Factor (CNTF), directly into the back of the eye by means of the Company's proprietary Encapsulated Cell Technology (ECT).